(Reuters) - Senior Cuban officials have over several weeks provided an increasingly dire snapshot of a deepening economic crisis in a series of televised prime-time appearances, revealing the extent of the downturn in unprecedented detail. Minister after minister have delivered…
By Jeffrey Dastin and Aditya Soni SAN FRANCISCO (Reuters) -Sam Altman is returning as CEO of OpenAI just days after his ouster, capping frenzied discussions about the future of the startup at the center of an artificial intelligence boom. The…
(Reuters) - Sam Altman reached an agreement with OpenAI to return as CEO on Wednesday, after a tumultuous few days following his ouster by the company's board. He joins a list of big name "boomerang" chief executives who have made…
SYDNEY (Reuters) - Australian home prices have defied a substantial jump in interest rates to hit a record high, data from property consultancy CoreLogic showed on Thursday, a sign that monetary policy might not be restrictive enough. Since finding a…
BEIJING (Reuters) - The head of China's civil aviation regulator, Song Zhiyong, met with the U.S. Ambassador in Beijing Nicholas Burns, and exchanged views on pushing for a substantial increase in flights between the two countries, the regulator said on…
A look at the day ahead in U.S. and global markets from Mike Dolan The mercurial world of artificial intelligence continues to grab most market headlines into the U.S. Thanksgiving holiday, while a temporary ceasefire in Gaza helped subdue already…
By Caroline Valetkevitch NEW YORK (Reuters) - U.S. stocks retreated on Tuesday, with the S&P 500 and Nasdaq snapping five-session winning streaks as retailers declined after some disappointing outlooks and as technology shares fell. Indexes stayed lower after minutes from…
By Richard Cowan and Moira Warburton WASHINGTON (Reuters) - The U.S. Congress is facing growing calls to find a way to stem rising budget deficits and debt following this month's warning by Moody's that political dysfunction could lead it to…
By Khushi Mandowara and Christy Santhosh (Reuters) -Medtronic raised its annual earnings forecast on Tuesday as strong sales in its surgical and diabetes units allayed concerns about the impact of new diabetes and weight-loss drugs on long-term growth, sending its…
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - Bayer's strategic review will consider a potentially tougher outlook for cash flows, its CEO said on Tuesday, after the German conglomerate suffered a major drug development setback. The group late on…
